The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,028.00
Bid: 12,012.00
Ask: 12,016.00
Change: -268.00 (-2.18%)
Spread: 4.00 (0.033%)
Open: 12,226.00
High: 12,266.00
Low: 11,988.00
Prev. Close: 12,296.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-End of lockdown? UK's Johnson mulls path out after 15 million vaccinated

Mon, 15th Feb 2021 07:43

* UK hits 15 million vaccination target

* UK PM Johnson to judge this week on lockdown exit

* UK looking at vaccine certificates to help Britons travel

* Hotel quarantine is going smoothly, minister says
(Recasts headline and lead)

By Guy Faulconbridge and Kate Holton

LONDON, Feb 15 (Reuters) - British Prime Minister Boris
Johnson will judge this week how fast England can exit COVID-19
lockdown after vaccinating 15 million of its most vulnerable
people, but the health minister said death and hospital
admission numbers were still too high.

With nearly a quarter of the United Kingdom's population now
inoculated with a first dose of a COVID vaccine in a little over
two months, Johnson is under pressure from some lawmakers and
businesses to reopen the shuttered economy.

"We've got to watch the data," Health Secretary Matt Hancock
told Sky News. "Everybody wants to get out of this as quickly as
we safely can, and both as quickly, but also as safely, are
important."

"The question is a judgement of how quickly and safely, how
quickly we can do that safely. That's the judgment that we're
making this week, looking at the data, ahead of the prime
minister setting out the roadmap, on the 22nd," he said.

The biggest and swiftest global vaccine rollout in history
is seen as the best chance of exiting the COVID-19 pandemic
which has killed 2.4 million people, tipped the global economy
into its worst peacetime slump since the Great Depression and
upended normal life for billions.

Britain has vaccinated 15.062 million people with a first
dose and 537,715 with a second dose, the fastest rollout per
capita of any large country.

VACCINE CERTIFICATES

Hancock said the British government was speaking to other
countries across the world about giving British people
certificates showing they had been vaccinated so that they could
travel abroad in the future to countries that require them.

"There is this international work going on because if other
countries require (proof of vaccination) we want to allow Brits
to be able to travel to those countries," Hancock said.

"We'd want to be able to facilitate that sort of vaccine
certification, but it isn't anything we're planning to introduce
here," he said, adding that a so-called vaccine passport was not
something that would be required to access services in the UK.

The United Kingdom has the world's fifth-worst official
death toll - currently 117,166 - after the United States,
Brazil, Mexico and India.

A new COVID-19 hotel quarantine system for arrivals from 33
"red list" countries, intended to limit the spread of new
variants of the virus, appears to be working smoothly a few
hours after it was introduced, Hancock said.

"As of 6.30, when I got my latest update, this is working
smoothly, we've been working with the airports and with the
border force to make sure everybody knows the process," Hancock
told Times Radio.
(Reporting by Guy Faulconbridge and Kate Holton; Editing by
James Davey and Peter Graff)

More News
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.